1-Benzyl-2,6-dioxo-N-(4-(trifluoromethoxy)phenyl)-1,2,3,6-tetrahydropyrimidine-4-carboxamide

Catalog No. :
ACXNZH441
CAS No. :
338412-65-0
Molecular Formula :
C19H14F3N3O4
Molecular Weight :
405.33

IUPAC Name:1-benzyl-2,6-dioxo-N-(4-(trifluoromethoxy)phenyl)-1,2,3,6-tetrahydropyrimidine-4-carboxamide

1-Benzyl-2,6-dioxo-N-(4-(trifluoromethoxy)phenyl)-1,2,3,6-tetrahydropyrimidine-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Benzyl-2,6-dioxo-N-(4-(trifluoromethoxy)phenyl)-1,2,3,6-tetrahydropyrimidine-4-carboxamide
IUPAC Name1-benzyl-2,6-dioxo-N-(4-(trifluoromethoxy)phenyl)-1,2,3,6-tetrahydropyrimidine-4-carboxamide
Molecular FormulaC19H14F3N3O4
Molecular Weight405.33
SMILESO=C(C(NC1=O)=CC(N1CC2=CC=CC=C2)=O)NC3=CC=C(OC(F)(F)F)C=C3
InChI KeyYQTATRMNSMEEIC-UHFFFAOYSA-N
Synonym1-BENZYL-6-HYDROXY-2-OXO-N-[4-(TRIFLUOROMETHOXY)PHENYL]-1,2-DIHYDRO-4-PYRIMIDINECARBOXAMIDE;1-benzyl-6-hydroxy-2-oxo-N-[4-(trifluoromethoxy)phenyl]-1,2-dihydropyrimidine-4-carboxamide;4-Pyrimidinecarboxamide, 1,2-dihydro-6-hydroxy-2-oxo-1-(phenylmethyl)-N-[4-(trifluoromethoxy)phenyl]-
CAS No.338412-65-0

Synthetic Route by SureRoute

1. ACXNZH441 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRCMF463 route compound structure diagram
    ACRCMF46342823-24-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXNZH441 route product structure diagram
    ACXNZH441338412-65-0
Inquiry

2. ACXNZH441 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRCMF463 route compound structure diagram
    ACRCMF46342823-24-5 In Stock
  4. Then
  5. ACXNZH441 route product structure diagram
    ACXNZH441338412-65-0
Inquiry

Comments (0)